We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+14.63%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$13.1B
AUM Growth
-$2.14B
Cap. Flow
-$3.3B
Cap. Flow %
-25.17%
Top 10 Hldgs %
30.62%
Holding
2,094
New
695
Increased
393
Reduced
360
Closed
644

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$361M
2
META icon
Meta Platforms (Facebook)
META
+$187M
3
DUK icon
Duke Energy
DUK
+$104M
4
XOM icon
ExxonMobil
XOM
+$102M
5
INTC icon
Intel
INTC
+$66.4M

Sector Composition

Rank Sector Weight
1 Technology 11.86%
2 Utilities 7.16%
3 Healthcare 6.86%
4 Industrials 6.78%
5 Real Estate 5.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCO icon
1526
Clear Channel Outdoor Holdings
CCO
$1.21B
-419,181
Closed -$763K
CDNA icon
1527
CareDx
CDNA
$2.51B
-31,246
Closed -$375K
CELH icon
1528
Celsius Holdings
CELH
$8.44B
-11,608
Closed -$633K
CERS icon
1529
Cerus
CERS
$566M
-42,085
Closed -$91K
CEVA icon
1530
CEVA Inc
CEVA
$788M
-38,980
Closed -$885K
CFR icon
1531
Cullen/Frost Bankers
CFR
$10.2B
-24,221
Closed -$2.63M
CGNX icon
1532
Cognex
CGNX
$10.2B
-13,791
Closed -$576K
CHDN icon
1533
Churchill Downs
CHDN
$6.53B
-1,887
Closed -$255K
CHCT
1534
Community Healthcare Trust
CHCT
$426M
-23,240
Closed -$619K
CHE icon
1535
Chemed
CHE
$7.07B
-514
Closed -$301K
CI icon
1536
Cigna
CI
$73.3B
-71,105
Closed -$21.3M
CIA icon
1537
Citizens
CIA
$190M
-39,723
Closed -$107K
CIEN icon
1538
Ciena
CIEN
$56B
-148,002
Closed -$6.66M
CIFR icon
1539
Cipher Digital
CIFR
$6.55B
-105,668
Closed -$436K
CINF icon
1540
Cincinnati Financial
CINF
$25.8B
-51,956
Closed -$5.38M
CL icon
1541
Colgate-Palmolive
CL
$72.6B
-24,033
Closed -$1.92M
CLB icon
1542
Core Laboratories
CLB
$574M
-18,643
Closed -$329K
CLNE icon
1543
Clean Energy Fuels
CLNE
$357M
-307,176
Closed -$1.18M
CMI icon
1544
Cummins
CMI
$80.9B
-158,133
Closed -$40.8M
CMPR icon
1545
Cimpress
CMPR
$2.13B
-14,591
Closed -$1.17M
CMPS
1546
Compass Pathways
CMPS
$1.85B
-277,209
Closed -$2.43M
CMTL icon
1547
Comtech Telecommunications
CMTL
$53M
-10,944
Closed -$92K
CNC icon
1548
Centene
CNC
$32.1B
-203,123
Closed -$15.1M
CNDT icon
1549
Conduent
CNDT
$250M
-838,073
Closed -$3.06M
CNK icon
1550
Cinemark Holdings
CNK
$4.24B
-42,022
Closed -$592K

Similar funds

Michael Gelband's Q1 2024 Portfolio in Review

As of Q1 2024, Michael Gelband held 2,094 positions worth $13.1B, down 14% from $15.2B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Michael Gelband withdrew a net $3.3B in Q1 2024, closing 644 positions and reducing 360 holdings. Its most notable exit was Fidelity National Information Services, an estimated $399M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 9.3% a quarter earlier, followed by Utilities and Healthcare.

Against the trend, Michael Gelband opened a new position in Duke Energy worth $106M.

  • Michael Gelband's largest Q1 2024 buy was Duke Energy: 1,098,157 shares worth $106M.
  • Michael Gelband added most to NVIDIA in Q1 2024, an estimated $361M increase.
  • Michael Gelband's biggest Q1 2024 reduction was CMS Energy, cutting an estimated $119M.
  • Michael Gelband fully exited Fidelity National Information Services in Q1 2024, selling an estimated $399M.
  • Michael Gelband's ten largest holdings make up 31% of its $13.1B portfolio in Q1 2024.
  • Michael Gelband opened 695 new positions and closed 644 in Q1 2024.
  • Michael Gelband's portfolio value fell 14% quarter-over-quarter to $13.1B.

Based on ExodusPoint Capital Management's 13F filing for Q1 2024, filed 14 May 2024.